Financial Updates for the Psychedelics Industry | Microdose

Psychedelics News

Finance

Breaking News, Finance, Press Releases

25 Feb 2025

Enveric Biosciences’ Patent For Non-Hallucinogenic Psychedelic Compounds

Enveric Biosciences (NASDAQ: ENVB) has received its first U.S. patent for the EVM401 Series, a collection of non-hallucinogenic compounds derived from mescaline. These novel therapeutics target multiple neurological receptors associated...

By Madison Roberts

Finance

8 May 2024

A Pioneering Push in Cancer Treatment: Enveric Biosciences Advances with Cannabinoid Therapies

Enveric Biosciences, a notable player in biotechnological innovations, has recently announced a significant licensing agreement that might change the landscape of cancer treatment....

By Madison Roberts

Finance

29 Apr 2024

Unlocking New Horizons: Enveric Biosciences’ Strategic Moves in Biotechnology

Enveric Biosciences has signed two non-binding term sheets to out-license novel cannabinoid-COX-2 conjugate compounds for joint disease treatment, with potential financial gains from milestone payments and royalties totaling up to...

By Madison Roberts

Finance

11 Dec 2023

Tryp Therapeutics To Be Acquired by Exopharm

Tryp Therapeutics announces signing of definitive agreement with Exopharm Limited....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance

18 Oct 2023

Spravato Sales Lead J&J Third Quarter Results

Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth....

By Jason Najum

Finance

13 Oct 2023

Cybin Shareholders Approve Acquisition of Small Pharma

Cybin shareholders approve the acquisition of Small Pharma with 99.4% of the vote....

By Microdose NewsDesk

Finance

18 Sep 2023

Billionaire Investor Steve Cohen Buys 19 million Shares of Cybin

Renowned billionaire investor Steve Cohen has purchased almost 19 million shares of Cybin....

By Jason Najum

Finance

15 Sep 2023

Beckley Waves Raises $3.3 Million Funding Round

Beckley Waves raises $3.3 million, capital to be used for investing in startups focused on infrastructure and services for psychedelic therapies....

By Microdose NewsDesk

Finance

26 Aug 2023

GH Research Reports Q2 2023 Financial Results and Business Update

GH Research has reported its second quarter 2023 financial results, with updates on trials and cash on hand....

By Microdose NewsDesk

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result